Time-restricted Feeding and Health
e-TRF
The Effect of Early Time-restricted Feeding in Metabolic Health - Differences Between Chronotypes.
1 other identifier
interventional
16
1 country
1
Brief Summary
The purpose of this pilot, single-arm clinical trial is to assess the effects of time-restricted feeding on overall health, including body composition, glycemic and lipidemic profile, as well as appetite-regulating hormones, including glucagon-like peptides 1(GLP-1) oxyntomodulin, glucagon. Additionally, the study aims to evaluate the impact of this dietary pattern on circadian rhythm parameters, including acrophase, mesor, and amplitude.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 16, 2025
CompletedFirst Submitted
Initial submission to the registry
January 15, 2026
CompletedFirst Posted
Study publicly available on registry
April 1, 2026
CompletedApril 1, 2026
March 1, 2026
7 months
January 15, 2026
March 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Changes from baseline in appetite-regulating hormones , including GLP-1 in pg/mL, oxyntomodulin in pg/mL, and glucagon in pg/mL at week 4, measured by ELISA kits.
Participants arrived at the laboratory between 08:30 and 09:00. An antecubital catheter was placed, and five blood samples were collected at fasting (0 min) and at 30, 60, 90, and 120 minutes after consuming the test meal. The test meal consisted of 100 g of S-Core FLEX Compact Protein powder (40 g carbohydrate, 29 g protein, 19 g fat) dissolved in 250 mL of water, providing 475 kcal.
Baseline and Week 4
Secondary Outcomes (3)
Changes from baseline in circadian rhythm parameters (acrophase in degrees of Celcious, mesor in time units, amplitude in degrees of Celcious) at week 4, measured through continouous measurements in skin termperature by a thermistor.
Baseline and Week 4
Changes from baseline in Body Composition, namely fat free mass in kg and fat mass in kg
Baseline and week 4
Changes from Baseline in Glycemic and Lipidemic Profile, assessed by photometry.
Baseline and Week 4
Study Arms (1)
Time-Restricted Feeding
OTHERParticipants followed a four-week regimen of ad libitum food intake from 08:00 to 18:00, followed by a 14-hour fasting period until 08:00 the next day, while maintaining habitual physical activity and sleep patterns.
Interventions
Ad libitum food intake from 08:00 to 18:00, followed by fasting from 18:00 to 08:00 for four weeks. Outside the eating window, water and limited amounts (1-2 servings) of very low-calorie items (e.g., tea, diet soft drinks, coffee, chewing gum \<4 kcal/serving) were permitted. The intervention focused exclusively on the timing of food intake and did not impose restrictions on the quantity or type of foods consumed.
Eligibility Criteria
You may qualify if:
- Healthy men or women aged 18-35 years
- Habitual daily eating window \>10 hours
- Stable body weight over the past 3 months (\< ±10% change)
- Able to provide informed consent independently
You may not qualify if:
- Night shift work more than once per week
- Presence of chronic diseases (e.g., cancer, renal or hepatic disease, inflammatory bowel disease, hypertension, diabetes, cognitive or psychiatric disorders)
- Eating disorders
- Use of medications affecting the intervention (e.g., corticosteroids, antidiabetics)
- Pregnancy or planning pregnancy within the next 12 months
- Diagnosis of insomnia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Harokopio University of Athens
Athens, Attica, 17676, Greece
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 15, 2026
First Posted
April 1, 2026
Study Start
June 4, 2025
Primary Completion
December 16, 2025
Study Completion
December 16, 2025
Last Updated
April 1, 2026
Record last verified: 2026-03